G. Panarace

Low Dose Atrial Natriuretic Factor in Primary Aldosteronism: Renal, Hemodynamic, and Vascular Effects

R. Pedrinelli, S. Favilla, S. Taddei, 1989, Hypertension.

Evidence for a systemic defect of resistance‐sized arterioles in hypertrophic cardiomyopathy

A. L'Abbate, R. Pedrinelli, R. Gistri, 1993, Coronary artery disease.

Does a digoxin-like substance participate in vascular and pressure control during dietary sodium changes in patients with primary aldosteronism?

R. Pedrinelli, S. Taddei, A. Salvetti, 1991, Journal of hypertension.

Atrial natriuretic factor as a vasodilator agent in hypertensive patients.

R. Pedrinelli, S. Favilla, S. Taddei, 1990, The American journal of the medical sciences.

Calcium entry blockade and adrenergic vascular reactivity in hypertensives: Differences between nicardipine and diltiazem

R. Pedrinelli, A. Salvetti, G. Panarace, 1991, Clinical pharmacology and therapeutics.

An atrial natriuretic factor analogue at low doses attenuates forearm reflex vasoconstriction to cardiopulmonary receptor deactivation in patients with hypertension.

R. Pedrinelli, S. Favilla, S. Taddei, 1991, American heart journal.

Calcium entry blockade and agonist-mediated forearm vasoconstriction in hypertensive patients. Difference between nicardipine and verapamil

R. Pedrinelli, S. Taddei, A. Salvetti, 2004, European Journal of Clinical Pharmacology.

Verapamil antagonizes forearm vasoconstriction mediated by selective alpha 1- and alpha 2-agonists in hypertensive patients.

R. Pedrinelli, S. Taddei, A. Salvetti, 1986, Journal of hypertension. Supplement : official journal of the International Society of Hypertension.

Calcium Entry Blockade and Agonist‐Mediated Vasoconstriction in Hypertensive Patients

R. Pedrinelli, S. Taddei, A. Salvetti, 1990, Journal of cardiovascular pharmacology.